SCHEMBL3918538

SCHEMBL3918538

COCc1ccccc1CNC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.47
ALDH1A1 P00352 3/20 0.47
LMNA P02545 1/20 0.47
KMT2A Q03164 3/20 0.45
NPC1 O15118 3/20 0.45
MEN1 O00255 2/20 0.45
RAB9A P51151 2/20 0.45
CACNA1G O43497 1/20 0.44
CACNA1H O95180 1/20 0.44
CACNA1I Q9P0X4 1/20 0.44
HTT P42858 3/20 0.44
GAA P10253 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9861981 0.86 SETDB1 (0.49) HPGDALDH1A1KMT2ANPC1MEN1
SCHEMBL9156343 0.84 CYP1A2 (0.55) HPGDALDH1A1LMNAKMT2ANPC1
SCHEMBL29935885 0.84 CYP1A2 (0.55) HPGDALDH1A1LMNAKMT2ANPC1
SCHEMBL15716617 0.84 NPSR1 (0.44) HPGDALDH1A1KMT2ANPC1MEN1
Hydrochloric Acid SCHEMBL11157053 0.82 CYP1A2 (0.53) HPGDALDH1A1LMNAKMT2ANPC1
SCHEMBL27682450 0.81 ALDH1A1 (0.53) HPGDALDH1A1LMNAKMT2ANPC1
SCHEMBL31531439 0.79 KMT2A (0.45) HPGDALDH1A1LMNAKMT2ANPC1
SCHEMBL2938380 0.79 KMT2A (0.69) HPGDALDH1A1KMT2ANPC1MEN1
SCHEMBL28716737 0.77 GAA (0.51) HPGDALDH1A1LMNANPC1RAB9A
SCHEMBL29501769 0.77 GAA (0.51) HPGDALDH1A1LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027096-B1 SUBSTITUTED ARYLIMIDAZ0L0NE AND TRIAZ0L0NE AS INHIBITORS OF VASOPRESSIN RECEPTORS Bayer Pharma AG (DE) 2012-05-23 EP disclosed
EP-2027096-A1 SUBSTITUTED ARYLIMIDAZ0L0NE AND TRIAZ0L0NE AS INHIBITORS OF VASOPRESSIN RECEPTORS Bayer HealthCare AG (DE) 2009-02-25 EP disclosed
WO-2007134862-A1 SUBSTITUTED ARYLIMIDAZ0L0NE AND TRIAZ0L0NE AS INHIBITORS OF VASOPRESSIN RECEPTORS BAYER HEALTHCARE AG (DE) 2007-11-29 WO disclosed